Literature DB >> 32500511

EMG Rectification Is Detrimental for Identifying Abnormalities in Corticomuscular and Intermuscular Coherence in Spinocerebellar Ataxia Type 2.

Yusely Ruiz-Gonzalez1, Luis Velázquez-Pérez2,3, Roberto Rodríguez-Labrada4, Reidenis Torres-Vega4, Ulf Ziemann5,6.   

Abstract

Corticomuscular and intermuscular coherence (CMC, IMC) reflect connectivity between neuronal activity in the motor cortex measured by electroencephalography (EEG) and muscular activity measured by electromyography (EMG), or between activity in different muscles, respectively. There is an ongoing debate on the appropriateness of EMG rectification prior to coherence estimation. This work examines the effects of EMG rectification in CMC and IMC estimation in 20 spinocerebellar ataxia type 2 (SCA2) patients, 16 prodromal SCA2 gene mutation carriers, and 26 healthy controls during a repetitive upper or lower limb motor task. Coherence estimations were performed using the non-rectified raw EMG signal vs. the rectified EMG signal. EMG rectification decreases the level of significance of lower beta-frequency band CMC and IMC values in SCA2 patients and prodromal SCA2 mutation carriers vs. healthy controls, and also results in overall lower coherence values. EMG rectification is detrimental for beta-frequency band CMC and IMC estimation. One likely reason for this effect is distortion of coherence estimation in high-frequency signals, where the level of amplitude cancelation is high.

Entities:  

Keywords:  Corticomuscular coherence; EEG; EMG; EMG rectification; Intermuscular coherence; Spinocerebellar ataxia type 2

Mesh:

Year:  2020        PMID: 32500511     DOI: 10.1007/s12311-020-01149-z

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  1 in total

1.  Variants in Genes of Calpain System as Modifiers of Spinocerebellar Ataxia Type 3 Phenotype.

Authors:  Ana Carolina Martins; Mariana Rieck; Vanessa Bielefeldt Leotti; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim
Journal:  J Mol Neurosci       Date:  2021-06-30       Impact factor: 3.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.